Hyperfine (HYPR) Stock: Buy, Sell, or Hold?
HYPR - Hyperfine, Inc. Class A Common Stock
$0.80
-0.05 (-6.04%)
▼
5d:
-5.76%
30d:
-0.14%
90d:
-18.53%
WAIT
LOW Confidence
Analysis Updated: Oct 14, 2026 12:00 AM ET
Earnings: Nov 09, 2026
24d
Get Alerted When HYPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HYPR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HYPR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: HYPR is currently trading at $0.80, which is considered extended relative to its 30-day fair value range of $0.78 to $0.87.
Technical Outlook: Technically, HYPR is in a strong downtrend. The price is currently testing key support at $0.79. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.03 (+154.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HYPR is in a strong downtrend. The price is currently testing key support at $0.79. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.03 (+154.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.78 -
$0.87
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
45.8%
Protect Your Profits
Holding HYPR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.0%)
- BULLISH: Trading 154.1% below Wall St target ($2.03)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.78 -
$0.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.79
Resistance Level
$1.05
Current Trend
Strong Downtrend
Technical data as of
Oct 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.50
Wall Street Target
$2.03
(+154.1%)
Revenue Growth (YoY)
44.8%
Profit Margin
-210.8%
Share & Embed Analysis
Last updated: October 15, 2026 9:41 AM ET
Data refreshes hourly during market hours. Next update: 10:41 AM
Data refreshes hourly during market hours. Next update: 10:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 66 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 49 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$364 | 53 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
27 analysts |
$107 | 61 BUY |
Advanced HYPR Option Strategies
Professional options setups generated by AI based on today's HYPR price and gamma walls.
